PB-1120

N/A

Report date: 2023/03/04 19:33:25
NME

Base Information

Drug NamePB-1120
Drug Alias NamePB-1120
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasoactive intestinal polypeptide receptor 1 agonistsVasoactive intestinal polypeptide receptor 2 agonists
TargetsVasoactive intestinal polypeptide receptor 1Vasoactive intestinal polypeptide receptor 2
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhasebio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPhasebio Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A